This is unpublished
OKRA/KOAR
Active Studies
Transplantation
Pinned
Principal Investigator
Nicolae Leca, MD
Funding Agency
Sponsor: CareDx, Inc.
Status
Active
Enrollment closed
Investigator
What is the OKRA/KOAR Study?
Evaluation of Patient Outcomes from the Kidney Allograft Outcomes Allosure Registry. The primary efficacy objective is to test the hypothesis that a strategy of monitoring for rejection that introduces AlloSure into clinical practice does not lead to inferior renal allograft outcomes compared to a strategy of monitoring for rejection that does not include AlloSure.
What are the criteria for the study?
Single de-novo or repeat renal transplant recipients selected to receive AlloSure testing as part of their routine care beginning within 2 months post-transplant
WHO DO I CONTACT FOR MORE INFORMATION?
Research Coordinator
Belinda Pan
E: bcpan@uw.edu